NCT00040547View on ClinicalTrials.gov

Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors (Study P01964)(COMPLETED)

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Neoplasms
Interventions
DRUG

Farnesyl Protein Transferase Inhibitor

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00040547 - Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors (Study P01964)(COMPLETED) | Biotech Hunter | Biotech Hunter